Challenging new targets for CNS-HIV infection

Challenging new targets for CNS-HIV infection

The central nervous system represents an important target for HIV infection during multiple stages of the disease: early, after invasion of the host, acting as a viral reservoir; lately, subverting its function and causing peripheral neuropathies and neurocognitive disorders; and lastly, during the...

Full description

Bibliographic Details
Main Authors:	Mario eGanau, Lara ePrisco, Daniele ePescador, Laura eGanau
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2012-03-01
Series:	Frontiers in Neurology
Subjects:	NeuroAIDS CNS-HIV infection Nanoformulated HAART
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fneur.2012.00043/full

Similar Items

Contribution of CNS cells in NeuroAIDS
by: Ashish Swarup Verma, et al.
Published: (2010-01-01)

Crossroads of Drug Abuse and HIV Infection: Neurotoxicity and CNS Reservoir
by: Shilpa Sonti, et al.
Published: (2022-01-01)

Connexin43 Containing Gap Junction Channels Facilitate HIV Bystander Toxicity: Implications in NeuroHIV
by: Shaily Malik, et al.
Published: (2017-12-01)

Editorial: Advances in Understanding NeuroHIV Associated Changes in Neuroimmune Communication in the Combined Anti-retroviral Therapy (cART) Era
by: Peter J. Gaskill, et al.
Published: (2021-10-01)

HIV-1 is Transported into the Central Nervous System by Trafficking Infected Cells
by: Laura Kincer, et al.
Published: (2023-01-01)

The dual action of poly(ADP-ribose) polymerase -1 (PARP-1) inhibition in HIV-1 infection: HIV-1 LTR inhibition and diminution in Rho GTPase activity
by: Slava eRom, et al.
Published: (2015-08-01)

Phenotypic changes in the brain of SIV-infected macaques exposed to methamphetamine parallel macrophage activation patterns induced by the common gamma-chain cytokine system
by: Nikki eBortell, et al.
Published: (2015-09-01)

Nose to brain delivery of antiretroviral drugs in the treatment of neuroAIDS
by: Anupam Sarma, et al.
Published: (2020-12-01)

Global Perspective of Novel Therapeutic Strategies for the Management of NeuroAIDS
by: Kumar Swatantra, et al.
Published: (2018-05-01)

Central HIV-1 Tat exposure elevates anxiety and fear conditioned responses of male mice concurrent with altered mu-opioid receptor-mediated G-protein activation and β-arrestin 2 activity in the forebrain
by: Yun K. Hahn, et al.
Published: (2016-08-01)

Challenging new targets for CNS–HIV infection
by: Ganau, M, et al.
Published: (2012)

Gene Co-Expression Network Modular Analysis Reveals Altered Immune Mechanisms in HIV-HAND
by: Maria Cristina Petralia, et al.
Published: (2022-10-01)

Antiepileptic Effect of Neuroaid<sup>®</sup> on Strychnine-Induced Convulsions in Mice
by: Ahmed Salim Mahmood, et al.
Published: (2022-11-01)

Boosting the Brain Delivery of Atazanavir through Nanostructured Lipid Carrier-Based Approach for Mitigating NeuroAIDS
by: Saif Ahmad Khan, et al.
Published: (2020-11-01)

Advances in SIV/SHIV Non-Human Primate Models of NeuroAIDS
by: Sonia Moretti, et al.
Published: (2021-08-01)

Lesões anorretais em pacientes HIV positivos usuários de terapia anti-retroviral de alta efetividade Anorrectal lesions in HIV-positive patients using highly active antiretroviral therapy
by: Manuel Retamozo-Palacios, et al.
Published: (2007-06-01)

Intranasal Administration of Dolutegravir-Loaded Nanoemulsion-Based In Situ Gel for Enhanced Bioavailability and Direct Brain Targeting
by: Anroop B. Nair, et al.
Published: (2023-02-01)

Intranasal Delivery of Darunavir-Loaded Mucoadhesive In Situ Gel: Experimental Design, In Vitro Evaluation, and Pharmacokinetic Studies
by: Anroop B. Nair, et al.
Published: (2022-05-01)

Prevention of mother-to-child transmission (PMTCT) of HIV: a review of the achievements and challenges in Burkina-Faso
by: Ghoma Linguissi LS, et al.
Published: (2019-07-01)

Nose to brain delivery of nanosuspensions with first line antiviral agents is alternative treatment option to Neuro-AIDS treatment
by: Smita P. Kakad, et al.
Published: (2022-07-01)

Identifying risk factors of immune reconstitution inflammatory syndrome in AIDS patients receiving highly active anti-retroviral therapy
by: Bo He, et al.

Identifying risk factors of immune reconstitution inflammatory syndrome in AIDS patients receiving highly active anti-retroviral therapy
by: Bo He, et al.
Published: (2013-04-01)

Condom use among HIV-Infected patients after initiation of highly Active Anti-Retroviral therapy (HAART): A cross sectional hospital based survey
by: B A Ezeala-Adikaibe, et al.
Published: (2017-01-01)

Human Endogenous Retrovirus-K and TDP-43 Expression Bridges ALS and HIV Neuropathology
by: Renée N. Douville, et al.
Published: (2017-10-01)

Enteric parasites in HIV-1/AIDS-infected patients from a Northwestern São Paulo reference unit in the highly active antiretroviral therapy era Enteroparasitas em pacientes infectados pelo HIV-1/AIDS em uma unidade de referência do noroeste paulista na era da terapia antirretroviral de alto impacto
by: Luciana Ventura Cardoso, et al.
Published: (2011-12-01)

Effect of Highly Active Antiretroviral Therapy on Fundus Images and Retinal Microvessel Diameter in HIV/AIDS Patients
by: Li Q, et al.
Published: (2023-01-01)

New Challenges of HIV-1 Infection: How HIV-1 Attacks and Resides in the Central Nervous System
by: Victoria Rojas-Celis, et al.
Published: (2019-10-01)

Serum Levels of Classical HLA Class I Antigen in HIV-Infected patients during antiretroviral therapy. Correlation with the clinical outcome
by: G. Murdaca, et al.
Published: (2009-01-01)

Overview of cancer incidence and mortality among people living with HIV/AIDS in British Columbia, Canada: Implications for HAART use and NADM development
by: Connie G. Chiu, et al.
Published: (2017-04-01)

Remission of a primary effusion lymphoma with initiation of highly active antiretroviral therapy and antiviral therapy in a previously untreated HIV-positive patient
by: Jacob Musinsky, et al.
Published: (2021-09-01)

Dyslipidemia and Nutritional Status of HIV-Infected Children and Adolescents on Antiretroviral Treatment at the Comprehensive Chronic Care and Training Center of Jimma Medical Center
by: Ambisa Lamesa T, et al.
Published: (2023-09-01)

Correlation between cytokine serum levels, number of CD4+ T cells/mm³ and viral load in HIV-1 infected individuals with or without antiretroviral therapy
by: D. A. Meira, et al.
Published: (2004-01-01)

Dyslipidemia in AIDS patients on highly active antiretroviral therapy
by: Max Weyler Nery, et al.

The man with bilateral nipple pain
by: Hong Hooi Chuen, et al.
Published: (2013-12-01)

Durability of the first combined antiretroviral regimen in patients with AIDS at a reference center in Belo Horizonte, Brazil, from 1996 to 2005
by: Flávia Andrade Ribeiro, et al.

HIV-Associated Cancer Biomarkers: A Requirement for Early Diagnosis
by: Zodwa Dlamini, et al.
Published: (2021-07-01)

Pencegahan dan Penatalaksanaan Infeksi HIV/AIDS Pada Kehamilan
by: Donel Suhaimi, et al.
Published: (2009-06-01)

Terapia hipolipemiante em situações especiais: síndrome de imunodeficiência adquirida Hypolipidemic therapy under special conditions: acquired immune deficiency syndrome
by: Pai Ching Yu, et al.
Published: (2005-10-01)

Chronic Kidney Disease and Associated Factors Among HIV/AIDS Patients on HAART in Ethiopia
by: Manaye GA, et al.
Published: (2020-10-01)

Aging with HIV: an overview of an urban cohort in Rio de Janeiro (Brazil) across decades of life
by: Thiago Silva Torres, et al.